The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-(4-Amino-6-(benzylamino)-1,3,5-triazin-2-yl)-4-fluorophenyl)methanol ID: ALA4525983
PubChem CID: 155543208
Max Phase: Preclinical
Molecular Formula: C17H16FN5O
Molecular Weight: 325.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(NCc2ccccc2)nc(-c2cc(F)ccc2CO)n1
Standard InChI: InChI=1S/C17H16FN5O/c18-13-7-6-12(10-24)14(8-13)15-21-16(19)23-17(22-15)20-9-11-4-2-1-3-5-11/h1-8,24H,9-10H2,(H3,19,20,21,22,23)
Standard InChI Key: SYMWMPOIYGREMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
35.9591 -25.7869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9580 -26.6064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6660 -27.0154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3757 -26.6059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3729 -25.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6642 -25.3780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0760 -25.3733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7855 -25.7810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4912 -25.3704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4886 -24.5523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7744 -24.1466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0716 -24.5595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.2003 -25.7766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9066 -25.3657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6157 -25.7720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6148 -26.5887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3230 -26.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0303 -26.5839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0250 -25.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3162 -25.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7684 -23.3294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6658 -27.8326 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.6618 -24.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9529 -24.1544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
9 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
11 21 1 0
3 22 1 0
6 23 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.35Molecular Weight (Monoisotopic): 325.1339AlogP: 2.36#Rotatable Bonds: 5Polar Surface Area: 96.95Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.33CX LogP: 3.29CX LogD: 3.26Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: -1.14
References 1. Yu X, Huang XP, Kenakin TP, Slocum ST, Chen X, Martini ML, Liu J, Jin J.. (2019) Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68)., 62 (16): [PMID:31298539 ] [10.1021/acs.jmedchem.9b00869 ]